<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="9169">Sisomicin</z:chebi>, at 4.5 mg/kg per day, was prescribed for the therapy of serious <z:mp ids='MP_0001794'>bacterial</z:mp> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> of hospitalized infants, children, and adolescents </plain></SENT>
<SENT sid="1" pm="."><plain>Eleven children received full treatment courses, with 10 clinical and 9 bacteriological cures </plain></SENT>
<SENT sid="2" pm="."><plain>Three patients with underlying disease (two cystic <z:mp ids='MP_0003045'>fibrosis</z:mp> and one <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>) accounted for the failures </plain></SENT>
<SENT sid="3" pm="."><plain>Mean half-life was 98.3 min (range, 26.1 to 159.3), and peak serum concentrations 10 min after intravenous infusion were similar (5 to 6 mug/ml) on days 1, 3, and 5 of therapy </plain></SENT>
<SENT sid="4" pm="."><plain>Mean urinary concentrations were 54.3 mug/ml; 31 to 47% of the drug was excreted within the 8-h dosage interval </plain></SENT>
<SENT sid="5" pm="."><plain>The drug was tolerated well by <z:hpo ids='HP_0000001'>all</z:hpo> patients; however, one patient, receiving the longest duration of therapy (26 days), developed reversible nephrotoxicity </plain></SENT>
</text></document>